Hippo pathway dysregulation is a common incident in GC, where the pathway includes two main downstream effectors, Yes-associated protein1 (YAP1) and transcriptional co-activator with PDZ-binding motif (TAZ) [19]. Here, YAP1 is linked to gastric cancer.